+ All Categories
Home > Documents > HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director,...

HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director,...

Date post: 29-Jan-2016
Category:
Upload: loren-cain
View: 222 times
Download: 0 times
Share this document with a friend
Popular Tags:
86
HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety at UNC Health Care; Research Professor of Medicine and Director, Statewide Program for Infection Control and Epidemiology at University of North Carolina School of Medicine at Chapel Hill, USA Disclosure: 3M
Transcript
Page 1: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

HLD and Sterilization:Current Issues and New Technologies

William A. Rutala, PhD, MPHDirector, Hospital Epidemiology, Occupational Health and Safety at UNC Health Care; Research Professor of

Medicine and Director, Statewide Program for Infection Control and Epidemiology at University of

North Carolina School of Medicine at Chapel Hill, USADisclosure: 3M

Page 2: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

HLD and Sterilization:Current Issues and New Technologies

SterilizationCleaning, washer disinfector, emerging technologies,

biological indicators, outpatient surgeries/procedures High-Level Disinfection

Endoscope-related infections, new HLD, channeled scopes, laryngoscopes, reuse of single-use items

D/S and Emerging PathogensMERS-CoV, HPV, C. difficile, Prions, Enterovirus 68, Ebola

Page 3: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

www.disinfectionandsterilization.org

Page 4: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

CDC Guideline for Disinfection and SterilizationRutala, Weber, HICPAC. November 2008. www.cdc.gov

Page 5: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Disinfection and Sterilization in Healthcare FacilitiesWA Rutala, DJ Weber, and HICPAC, www.cdc.gov

Overview Last Centers for Disease Control and Prevention guideline

in 1985 158 pages (>82 pages preamble, 34 pages

recommendations, glossary of terms, tables/figures, >1000 references)

Evidence-based guideline Cleared by HICPAC February 2003; delayed by FDA Published in November 2008

Page 6: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

HLD and Sterilization:Current Issues and New Technologies

SterilizationCleaning, washer disinfector, emerging technologies,

biological indicators, outpatient surgeries/procedures High-Level Disinfection

Endoscope-related infections, new HLD, channeled scopes, laryngoscopes, reuse of single-use items

D/S and Emerging PathogensMERS-CoV, HPV, C. difficile, Prions, Enterovirus 68, Ebola

Page 7: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Disinfection and SterilizationWA Rutala, DJ Weber, and HICPAC, www.cdc.gov

EH Spaulding believed that how an object will be disinfected depended on the object’s intended use.

CRITICAL - objects which enter normally sterile tissue or the vascular system or through which blood flows should be sterile.

SEMICRITICAL - objects that touch mucous membranes or skin that is not intact require a disinfection process (high-level disinfection [HLD]) that kills all microorganisms but high numbers of bacterial spores.

NONCRITICAL -objects that touch only intact skin require low-level disinfection (or non-germicidal detergent).

Page 8: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Efficacy of Disinfection/Sterilization Influencing Factors

WA Rutala, DJ Weber, and HICPAC, www.cdc.gov

Cleaning of the objectOrganic and inorganic load presentType and level of microbial contaminationConcentration of and exposure time to disinfectant/sterilantNature of the objectTemperature and relative humidity

Page 9: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Cleaning Items must be cleaned using water with detergents or

enzymatic cleaners before processing. Cleaning reduces the bioburden and removes foreign

material (organic residue and inorganic salts) that interferes with the sterilization process.

Cleaning and decontamination should be done as soon as possible after the items have been used as soiled materials become dried onto the instruments.

Page 10: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Cleaning Mechanical cleaning machines-automated equipment may

increase productivity, improve cleaning effectiveness, and decrease worker exposure Utensil washer-sanitizer Ultrasonic cleaner Washer sterilizer Dishwasher Washer disinfector

Manual

Page 11: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.
Page 12: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.
Page 13: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.
Page 14: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Bioburden on Surgical DevicesNon-lumen Surgical Instruments Carry a Low Microbial Load (<100 CFU, 85%)

Bioburden on instruments used in surgery (Nystrom, J Hosp Infect 1981) 62% contaminated with <101

82% contaminated with <102

91% contaminated with <103

Bioburden on surgical instruments (Rutala, Am J Infect Control 1997) 72% contained <101

86% contained <102

Bioburden on surgical instruments (50) submitted to CP (Rutala, AJIC 2014) 58% contained <10 20% contained < 102

16% contained <5x102

6% contained <103

Page 15: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Washer/DisinfectorRutala WA et al. Infect Control Hosp Epidemiol 2014;35:883-885

• Five Chambers Pre-wash: water/enzymatic is circulated over the load for 1 min Wash: detergent wash solution (150oF) is sprayed over load for 4 min Ultrasonic cleaning: basket is lowered into ultrasonic cleaning tank

with detergent for 4 min Thermal and lubricant rinse: hot water (180oF) is sprayed over load

for 1 min; instrument milk lubricant is added to the water and is sprayed over the load

Drying: blower starts for 4 min and temperature in drying chamber 180F

Page 16: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.
Page 17: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Washer/DisinfectorRemoval/Inactivation of Inoculum (Exposed) on Instruments

Rutala et al. Infect Control Hosp Epidemiol 2014. 35:883-885.

WD Conditions Organism Inoculum Log Reduction Positives

Routine MRSA 2.6x107 Complete 0/8

Routine VRE 2.6x107 Complete 0/8

Routine P aeruginosa 2.1x107 Complete 0/8

Routine M terrae 1.4x108 7.8 2/8

Routine GS spores 5.3x106 4.8 11/14

No Enz/Det VRE 2.5x107 Complete 0/10

No Enz/Det GS spores 8.3x106 5.5 8/10

Page 18: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Washer/disinfectors are very effective (>7 log10 reduction) in removing/inactivating

microorganisms from instruments

Page 19: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Cleaning Indicators for Washer Disinfector Monitor the automated washer and

instrument cleaning chemistry functionality; AAMI recommends weekly (preferably daily)

Washer indicators have been used in Europe and Canada and some US hospitals

Indicator includes proteins, lipids, and polysaccharides to mimic common challenging test soils

Washer indicators are chemical indicators imprinted with a dried test soil formula and a dye

Page 20: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

How Clean Is Clean? AAMI and FDA trying to gain consensus Reached consensus on maximum levels of top three common markers

after a device is cleaned Less than 6.4 µg/cm2 for protein Less than 12 µg/cm2 for total organic compound Less than 2.2 µg/cm2 for hemoglobin

Research needs to be performed to determine how healthcare facilities should verify cleanliness (real-time tests and meaningful analytical endpoints)

Manufacturers’ ensure the HCF can clean the device (time, resources, device design)

Page 21: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Methods in Sterilization

Page 22: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.
Page 23: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Sterilization of “Critical Objects”

Steam sterilization-1970sEthylene oxide-1970s

Hydrogen peroxide gas plasma-1993Vaporized hydrogen peroxide-2011

Page 24: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Emerging Technologies

Page 25: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Ozone and Hydrogen Peroxide

Sterizone VP4, 510(k) FDA clearance,TSO3 Canada Sterilizer has a 4.4ft3 chamber Advantages/Disadvantages-not yet known

Page 26: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Nitrogen Dioxide(Noxilizer, MD 2004; seeking industrial claim; 2016 HC)

NO2 has unique properties including a low boiling point (21oC) and a high vapor pressure, which facilitate effective dispersion of NO2 gas at low concentration

Log-linear inactivation at 3.5mg/L NO2 gas concentration and 75% RH using G. stearothermophilus spores

Toxicity-OSHA PEL for NO2 is 5ppm Compatible with most polymers used in medical devices

Page 27: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

New LTST Technology Supercritical CO2

Peracetic acid vapor Gaseous chlorine dioxide

Page 28: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Biological Indicators • Select BIs that contain spores of

Bacillus atrophaeus

• Rationale: BIs are the onlysterilization process monitoringdevice that provides a direct measure of the lethality of the process

Bacillus atrophaeus

Page 29: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Rapid Readout BIs for Steam Now Require a 1-3h Readout Compared to 24-48h

Rutala, Jones, Weber ICHE 1996. 17:423

Page 30: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Super Rapid Readout Biological IndicatorsCommercially available

1491 BI (blue cap)• Monitors 270°F and 275°F gravity –displacement steam sterilization cycles• 30 minute result (from 1hour)

1492V BI (brown cap)• Monitors 270°F and 275°F dynamic-air-removal (pre-vacuum) steam sterilization cycles• 1 hour result (from 3 hours)

Page 31: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Routine Load Release/Routine Sterilizer Efficacy Monitoring Ethylene Oxide Sterilizers

BI Process Challenge Device• BI placed in PCD representative of

packs being sterilized• AAMI routine test pack or commercially

available, FDA cleared BI PCD• Placement: Full load in center• Frequency: in each load• Attest™ 1298 Test Pack contains Attest

1294™ Rapid Readout BI for EO with 4 hour final result

ANSI/AAMI ST41:2008( R)2012, Section 10

Page 32: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

US Outpatient Surgery/Procedures Pass

Inpatient Surgery/Procedure

Page 33: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Outpatient vs Inpatient Surgery/Procedure2010, US DHHS

Top 10 Outpatient Surg/Proc-53M Lens and cataract procedures-7M Endoscopy of large intestine-5.7M Endoscopy of small intestine-3.4M Therapeutic injections-1.4M Coronary artery exam-1M Knee arthroscopy-~1M Hernia repair-~1M Tonsillectomy/adenoidectomy-750K Cystoscopy-750K

Top 10 Inpatient Surg/Proc-46M Coronary artery exam-1M C-section 1.3M Cardiac cath-1.1M Endoscopy of small intestine-1M Diagnostic ultrasound-~900K CAT scans-740K Realign broken bone-672K Balloon angioplasty of coronary-661K Coronary artery stent-661K

Page 34: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

HLD and Sterilization:Current Issues and New Technologies

SterilizationCleaning, washer disinfector, emerging technologies,

biological indicators, outpatient surgeries/procedures High-Level Disinfection

Endoscope-related infections, new HLD, channeled scopes, laryngoscopes, reuse of single-use items

D/S and Emerging PathogensMERS-CoV, HPV, C. difficile, Prions, Enterovirus 68, Ebola

Page 35: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

DISINFECTION AND STERILIZATION

• EH Spaulding believed that how an object will be disinfected depended on the object’s intended use CRITICAL - objects which enter normally sterile tissue or the

vascular system or through which blood flows should be sterile SEMICRITICAL - objects that touch mucous membranes or skin

that is not intact require a disinfection process (high-level disinfection[HLD]) that kills all microorganisms except for high numbers of bacterial spores

NONCRITICAL - objects that touch only intact skin require low-level disinfection

Page 36: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

High-Level Disinfection of “Semicritical Objects”

Exposure Time > 8m-45m (US), 20oCGermicide Concentration_____Glutaraldehyde > 2.0%Ortho-phthalaldehyde 0.55%Hydrogen peroxide* 7.5%Hydrogen peroxide and peracetic acid* 1.0%/0.08%Hydrogen peroxide and peracetic acid* 7.5%/0.23%Hypochlorite (free chlorine)* 650-675 ppmAccelerated hydrogen peroxide 2.0%Peracetic acid 0.2%Glut and isopropanol 3.4%/26%Glut and phenol/phenate** 1.21%/1.93%___*May cause cosmetic and functional damage; **efficacy not verified

Page 37: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

ResertTM HLD High Level Disinfectant - Chemosterilant 2% hydrogen peroxide, in formulation

pH stabilizers Chelating agents Corrosion inhibitors

Efficacy (claims need verification) Sporicidal, virucidal, bactericidal, tuberculocidal, fungicidal

HLD: 8 mins at 20oC Odorless, non-staining, ready-to-use No special shipping or venting requirements Manual or automated applications 12-month shelf life, 21 days reuse Material compatibility/organic material resistance (Fe, Cu)?

*The Accelerated Hydrogen Peroxide technology and logo are the property of Virox Technologies, Inc. Modified from G MacDonald. AJIC 2006;34:571

Page 38: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Reprocessing Semicritical Items

New Developments in Reprocessing Endoscopes Cystoscopes, ureteroscopes, hysteroscopes Prostate probes Laryngoscopes

Page 39: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Reprocessing Semicritical Items

New Developments in Reprocessing Endoscopes Cystoscopes, ureteroscopes, hysteroscopes Prostate probes Laryngoscopes

Page 40: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

“Superbug” Outbreaks

Cedars-Sinai Medical Center, UCLA Ronald Reagan Medical Center, University of Pittsburgh Medical Center, Virginia Mason Medical Center, tertiary care facility in NE Illinois

ABC, CBS, NBC, CNN, New York Times, LA Times Congress asked the FDA why “didn’t move more quickly and

aggressively to ensure patient safety” Professional organizations (ASGE, AGA) and FDA

investigating

Page 41: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

GI ENDOSCOPES Widely used diagnostic and therapeutic procedure (~20 million GI

procedures annually in the US) GI endoscope contamination during use (107-10 in/105 out) Semicritical items require high-level disinfection minimally Inappropriate cleaning and disinfection has lead to cross-transmission In the inanimate environment, although the incidence remains very

low, endoscopes represent a significant risk of disease transmission. In fact, more outbreaks of infection associated with endoscopes than any reusable medical device in healthcare.

Page 42: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Transmission of Infection by EndoscopyKovaleva et al. Clin Microbiol Rev 2013. 26:231-254

Scope Outbreaks Micro (primary) Pts Contaminated

Pts Infected Cause (primary)

Upper GI 19 Pa, H. pylori, Salmonella

169 56 Cleaning/Dis-infection (C/D)

Sigmoid/Colonoscopy

5 Salmonella, HCV 14 6 Cleaning/Dis-infection

ERCP 23 Pa 152 89 C/D, water bottle, AER

Bronchoscopy 51 Pa, Mtb,Mycobacteria

778 98 C/D, AER, water

Totals 98 1113 249Based on outbreak data, if eliminated deficiencies associated with cleaning, disinfection, AER , contaminated water and drying would eliminate about 85% of the outbreaks.

Page 43: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Nosocomial Infections via GI Endoscopes• Infections traced to deficient practices

Inadequate cleaning (clean all channels) Inappropriate/ineffective disinfection (time exposure, perfuse

channels, test concentration, ineffective disinfectant, inappropriate disinfectant)

Failure to follow recommended disinfection practices (tapwater rinse)

Flaws and complexity in design of endoscopes or AERs

Page 44: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Recent Outbreaks When Manufacturer’s Instructions and Professional Guidelines Followed

Epstein et al. JAMA 2014;312:1447-1455 (NE IL) Wendorf et al. ICHE 2015 (Seattle) At least four other CRE outbreaks related to ERCP

UCLA Ronald Reagan Medical Center Cedar Sinai Medical Center Univ of Pittsburgh Medical Center Wisconsin medical facility

Page 45: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

ENDOSCOPE REPROCESSING: CHALLENGESNDM-Producing E. coli Associated ERCP

MMWR 2014;62:1051; Epstein et al. JAMA 2014;312:1447-1455

NDM-producing E.coli recovered from elevator channel (elevator channel orients catheters, guide wires and accessories into the endoscope visual field; crevices difficult to access with cleaning brush and may impede effective reprocessing or killing CRE)

Page 46: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Reason for Endoscope-Related OutbreaksRutala WA, Weber WA. Infect Control Hosp Epidemiol 2015, In press

Margin of safety with endoscope reprocessing minimal or non-existent for two reasons:

Microbial load GI endoscopes contain 107-10

Cleaning results in 2-6 log10 reduction

High-level disinfection results in 4-6 log10 reduction

Results in a total 6-12 log10 reduction of microbes

Level of contamination after processing: 4 log10 (maximum contamination, minimal cleaning/HLD)

Complexity of endoscope

Page 47: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Reason for Endoscope-Related OutbreaksRutala WA, Weber WA. Infect Control Hosp Epidemiol 2015, In press

Margin of safety with endoscope reprocessing minimal or non-existent Microbial load

GI endoscopes contain 107-10

Cleaning results in 2-6 log10 reduction

High-level disinfection results in 4-6 log10 reduction

Results in a total 6-12 log10 reduction of microbes

Level of contamination after processing: 4log10 (maximum contamination, minimal cleaning/HLD)

Complexity of endoscope Biofilms-unclear if contribute to failure of endoscope reprocessing

Page 48: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

BIOFILMS(Multi-layered bacteria plus exopolysaccharides that cement cell to surface; develop in wet environments; if reprocessing performed promptly after use and endoscope dry the

opportunity for biofilm formation is minimal)

Page 49: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Reason for Endoscope-Related OutbreaksRutala WA, Weber WA. Infect Control Hosp Epidemiol 2015, In press

Margin of safety with endoscope reprocessing minimal or non-existent for two reasons:

Microbial load GI endoscopes contain 107-10

Cleaning results in 2-6 log10 reduction

High-level disinfection results in 4-6 log10 reduction

Results in a total 6-12 log10 reduction of microbes

Level of contamination after processing: 4log10 (maximum contamination, minimal cleaning/HLD

Complexity of endoscope

Page 50: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

ENDOSCOPE REPROCESSING: CHALLENGES

Complex [elevator channel]-109 bacteria Surgical instruments-<102 bacteria

Page 51: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

ENDOSCOPE REPROCESSING

Page 52: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

FEATURES OF ENDOSCOPES THAT PREDISPOSE TO DISINFECTION FAILURES

Heat labile Long, narrow lumens Right angle bends Rough or pitted surfaces Springs and valves Damaged channels may impede

microbial exposure to HLD Heavily contaminated with

pathogens, 107-10

Cleaning (4-6 log10 reduction) and HLD (4-6 log10 reduction) essential for patient safe instrument

Page 53: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

What Should We Do Now?

Page 54: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Current Enhanced Methods for Reprocessing Duodenoscopes

Hospitals performing ERCPs should do one of the following (priority ranked); doing nothing is not an option:Ethylene oxide sterilization after high level disinfection with periodic microbiologic surveillanceDouble high-level disinfection with periodic microbiologic surveillanceHigh-level disinfection with scope quarantine until negative cultureLiquid chemical sterilant processing system using peracetic acid (rinsed with extensively treated potable water) with periodic microbiologic surveillanceHigh-level disinfection with periodic microbiologic surveillance

Page 55: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Summary of Advantages and Disadvantages of HLD and Sterilization Enhancements for Reprocessing Duodenoscopes

Rutala WA, Weber WA. Infect Control Hosp Epidemiol 2015, In press

Method Advantages Disadvantages

HLD with ETO

• Major endoscope manufacturer offers ETO as sterilization option

• Ideally, should be used after standard high-level disinfection

• Some data demonstrate reduced infection risk with HLD followed by ETO

• Single-dose cartridge and negative- pressure chamber minimizes the potential for gas leak and ETO exposure

• Simple to operate and monitor• Compatible with most medical materials

• Requires aeration time to remove ETO residue

• Only 20% of US hospitals have ETO on-site

• Lengthy cycle/aeration time• No microbicidal efficacy data

proving SAL 10-6 achieved• Studies question microbicidal

activity in presence of organic matter/salt

• ETO is toxic, a carcinogen, flammable

• May damage endoscope

Page 56: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Summary of Advantages and Disadvantages of HLD and Sterilization Enhancements for Reprocessing Duodenoscopes

Rutala WA, Weber WA. Infect Control Hosp Epidemiol 2015, In press

Method Advantages Disadvantages

HLD, Microbiologic surveillance

• HLD inactivate MDR organisms including CREs

• Microbiologic surveillance offered as supplement by CDC

• Based on recent ERCP outbreaks, infection risk related to device complexity and microbial load

• No data demonstrating reduced infection risk

• Sensitivity of microbiologic surveillance unknown

• 48-72 hours before culture results known

• No consensus regarding sampling scheme, 100% or 10% of scopes per week/per month?

• No cutoff to define effective disinfection (0 GNR?)

Page 57: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Summary of Advantages and Disadvantages of HLD and Sterilization Enhancements for Reprocessing Duodenoscopes

Rutala WA, Weber WA. Infect Control Hosp Epidemiol 2015, In press

Method Advantages Disadvantages

HLD only (not listed as an enhanced method for reprocessing endoscope)

• HLD inactivate MDR organisms including CREs

• Current standard of care• Wide availability

• Based on recent ERCP outbreaks, infection risk related to device complexity and microbial load

• No enhancement to reduce infection risk associated with ERCP scopes

• Some HLD (e.g., aldehydes) may cross-link proteins

Page 58: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Summary of Advantages and Disadvantages of HLD and Sterilization Enhancements for Reprocessing Duodenoscopes

Rutala WA, Weber WA. Infect Control Hosp Epidemiol 2015, In press

Method Advantages Disadvantages

HLD, ATP (not listed as an enhanced method for reprocessing endoscope)

• HLD inactivate MDR organisms including CREs

• Real-time monitoring tool• Simple to conduct• Detects organic residue

• Based on recent ERCP outbreaks, infection risk related to device complexity and microbial load

• No data demonstrating reduced infection risk

• Does not detect microbial contamination

• ATP not validated as risk factor for patient-to-patient transmission

• Unknown cut-off level to assure safety

Page 59: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Adenosine Triphosphate (ATP) ValidationAlfa et al. Am J Infect Control 2013;41:245

Validated as a monitoring tool for assessing cleaning because it detects organic residuals

ATP is not a good indicator of microbial contamination and has not been validated as a method to assess the risk of patient-to-patient transmission

ATP <200 RLU benchmark for clean, equates to <4 log10 CFUs/cm2 or 106 CFUs per endoscope

Thus, an endoscope assessed as clean using ATP could still have a significant microbial load (e.g., 106)

Page 60: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

To protect the public health we must shift endoscope reprocessing from HLD

to sterilization. FDA should mandate that GI endoscopes used in healthcare

facilities be sterile by 2018.

Page 61: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

GI Endoscopes: Shift from Disinfection to Sterilization

Rutala, Weber. JAMA 2014. 312:1405-1406

Page 62: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Potential Future Methods to Prevent GI-Endoscope Related Outbreaks

Rutala WA, Weber WA. Infect Control Hosp Epidemiol 2015, In press

Steam sterilizable GI endoscopes New low temperature sterilization methods proving SAL 10-6

achieved (or optimizing current LTST) Disposable sterile GI endoscopes Improved GI endoscope design (to reduce or eliminate

challenges listed above) Use of non-endoscope methods to diagnosis or treat disease

(e.g., capsule endoscopy, blood tests to detect GI cancer, stool DNA test)

Page 63: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Reprocessing Semicritical Items

New Developments in Reprocessing Endoscopes Cystoscopes, ureteroscopes, hysteroscopes Prostate probes Laryngoscopes

Page 64: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Reprocessing Channeled EndoscopesCystoscopes, Ureteroscopes, Hysteroscopes

Page 65: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Reprocessing Channeled EndoscopesRutala, Gergen, Bringhurst, Weber. 2015

Exposure Method

VRE Contamination Before HLD (glutaraldehyde)

VRE Contamination After HLD

Passive HLD(immersed, not perfused)

3.6x108

2.0x108

1.1x108

7.5x108

1.0x108

6.8x107

Active HLD (perfused HLD into channel with syringe)

8.4x107

1.5x108

2.8x108

1 CFU00

Pathogens must have exposure to HLD for inactivation

Immerse channeled flexible scope into HLD will not inactivate channel pathogens

Completely immerse the endoscope in HLD and ensure all channels are perfused

Air pressure in channel stronger than fluid pressure at fluid-air interface

Page 66: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Prostate Biopsy Probe Evaluated effectiveness of HLD when assembled (needle

biopsy holder in probe) and unassembled. Inoculated (106-107 P.aeruginosa): internal lumen/outside

surface of needle biopsy holder; internal lumen of probe with and without needle biopsy holder in place

Conclusion: HLD achieved when unassembled but not when assembled

Page 67: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.
Page 68: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Disinfection of Prostate ProbeRutala, Gergen, Weber. ICHE. 2007;28:916

Needle guide must be removed from the probe for disinfection

Page 69: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Disinfection of Prostate ProbeRutala, Gergen, Weber. ICHE; 2007;28:916

Page 70: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Do Not Reuse Single Use Devices Federal judge convicted a

urologist who reused needle guides meant for single use during prostate procedures (Sept 2014)

Third party reprocessor OK Criminal prosecution

(based on conspiracy to commit adulteration)

Page 71: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.
Page 72: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Reprocessing of Rigid LaryngoscopesJHI 2008, 68:101; ICHE 2007, 28:504; AJIC 2007, 35: 536

Limited guidelines for reprocessing laryngoscope’s blades and handles

Many hospitals consider blade as semicritical (HLD) and handle as noncritical (LLD)

Blades linked to HAIs; handles not directly linked to HAIs but contamination with blood/OPIM suggest its potential and blade and handle function together

Ideally, clean then HLD/sterilize blades and handles (UNCHC-blades wrapped in a tray-Sterrad; handle wrapped in tray [without batteries]-steam); the blades and handles placed together in a Ziploc bag. Blades and handles checked for function prior to packaging.

Page 73: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Contamination of Laryngoscope Handles

J Hosp Infect 2010;74:123 55/64 (86%) of the handles deemed “ready for patient use” positive for

S. aureus, enterococci, Klebsiella, Acinetobacter

Anesth Analg 2009;109:479 30/40 (75%) samples from handles positive (CONS, Bacillus,

Streptococcus, S. aureus, Enterococcus) after cleaning

AANA J 1997;65:241 26/65 (40%) of the handles and 13/65 (20%) of the blades were positive

for occult blood. These blades and handles were identified as ready for patient use.

Page 74: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.
Page 75: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.
Page 76: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Laryngoscopes BladesThe Joint Commission, FAQ, October 24, 2011

How should we process and store laryngoscope blades? Processed via sterilization or HLD Packaged in some way Stored in a way that prevents recontamination. Examples

of compliant storage include, but are not limited to, a peel pack post steam sterilization (long-term) or wrapping in a sterile towel (short term)

Should not place unwrapped blades in an anesthesia drawer

Page 77: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

HLD and Sterilization:Current Issues and New Technologies

SterilizationCleaning, washer disinfector, emerging technologies,

biological indicators, outpatient surgeries/procedures High-Level Disinfection

Endoscope-related infections, new HLD, channeled scopes, laryngoscopes, reuse of single-use items

D/S and Emerging PathogensMERS-CoV, HPV, C. difficile, Prions, Enterovirus 68, Ebola

Page 78: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Decreasing Order of Resistance of Microorganisms to Disinfectants/Sterilants

PrionsBacterial spores (C. difficile)

MycobacteriaSmall, non-enveloped viruses (HPV, polio, EV-D68)

Fungal sporesGram-negative bacilli (Acinetobacter)

Vegetative fungi and algaeLarge, non-enveloped viruses

Gram-positive bacteria (MRSA, VRE)Enveloped viruses (Ebola, MERS-CoV)

Most Resistant

Most Susceptible

LLD-kill microbes in “green”; HLD kill microbes in “blue”

Page 79: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Norovirus, C. difficile spores, MERS-CoV, Enterovirus D68, Ebola, MDR organisms such carbapenemase-

producing Enterobacteriaceae (CRE)

•In general, emerging pathogens are susceptible to currently available

disinfectants. However, some pathogens need additional information (e.g., prions,

C. difficile spores).

Page 80: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Decreasing Order of Resistance of Microorganisms to Disinfectants/Sterilants

PrionsBacterial spores (C. difficile)

MycobacteriaSmall, non-enveloped viruses (HPV, polio, EV-D68)

Fungal sporesGram-negative bacilli (Acinetobacter)

Vegetative fungi and algaeLarge, non-enveloped viruses

Gram-positive bacteria (MRSA, VRE)Enveloped viruses (Ebola, MERS-CoV)

Most Resistant

Most Susceptible

Page 81: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

C. Difficile Spores EPA-Registered Products

• List K: EPA’s Registered Antimicrobials Products Effective Against C. difficile spores, April 2014

• http://www.epa.gov/oppad001/list_k_clostridium.pdf• 34 registered products; most chlorine-based, some

HP/PA-based, PA with silver

Page 82: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

SHEA Prion GuidelineRutala, Weber. Infect Control Hosp Epidemiol 2010;31:107

Page 83: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

Management of Neurosurgical Instruments and Patients Exposed to CJD

Conventional sterilization/disinfection inadequate for prions. Need special prion reprocessing (critical/semi device contaminated with high risk tissue from high-risk patient)

Belay et al. ICHE 2014;34:1272. Decontamination options combine chemical and SS-1) immerse in 1N NaOH and heat in gravity at ≥121C for 30m in appropriate container; 2) immerse in 1N NaOH or NaOCl 20,000ppm 1h then transfer into water and autoclave at ≥121C for 1h; 3) immerse in 1N NaOH or NaOCl 20,000ppm 1h, rinse with water, transfer to pan and autoclave at 121C (gravity) or 134C (porous) for 1 hour. Clean and sterilize by conventional means.

Thomas et al. J Clin Neurosci 2013;20:1207. Reviews prevention strategies McDonnell et al. J Hosp Infect. 2013;85:268. Investigates the combination of cleaning,

disinfection and/or sterilization on prions Rutala, Weber. ICHE 2010;31:107. SHEA Guideline-134C for 18m in prevacuum or

NaOH/autoclave (such as CDC option 2)

Page 84: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

HLD and Sterilization:Current Issues and New Technologies

SterilizationCleaning, washer disinfector, emerging technologies,

biological indicators, outpatient surgeries/procedures High-Level Disinfection

Endoscope-related infections, new HLD, channeled scopes, laryngoscopes, reuse of single-use items

D/S and Emerging PathogensMERS-CoV, HPV, C. difficile, Prions, Enterovirus 68, Ebola

Page 85: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

High-Level Disinfection and Sterilization: Current Issues and New Technologies

• New D/S technologies (new disinfectants, BIs, washer disinfectors) and practices (e.g., perfused channel scopes with HLD) could reduce risk of infection.

• Endoscope represent a nosocomial hazard. Endoscopes have narrow margin of safety due to complexity and microbial load. Urgent need to develop methods to reduce GI-endoscope-related outbreaks (e.g., new/optimized LTST, steam sterilizable GI scopes, improved scope design, etc).

• Do not reuse single-use devices• In general, emerging pathogens are susceptible to currently available

disinfectants. However, some pathogens need additional information (e.g., prions, C. difficile spores).

Page 86: HLD and Sterilization: Current Issues and New Technologies William A. Rutala, PhD, MPH Director, Hospital Epidemiology, Occupational Health and Safety.

THANK YOU!www.disinfectionandsterilization.org


Recommended